Record Revenue of $291.0 Million; Backlog of $2.8 Billion
Argan, Inc. (NYSE: AGX) (“Argan” or the “Company”) today announced that the Company will release its first quarter fiscal 2027 financial results after the market closes on Thursday, June 4, 2026. Management will host a webcast with an accompanying slide presentation and conference call on Thursday, June 4, 2026 at 5:00 p.m. ET. Participants can [...]
ReNew Announces Results for the Fourth Quarter and Full Fiscal Year: Reports Highest Ever Net Profit
Net Profit jumped 2.3x during the year ended March 31, 2026 Increase in net profit driven by higher operating portfolio, lower leverage and growth in manufacturing business Commissioned 2.4GW of capacity, its highest ever, during the year ended March 31, 2026
Net cash provided by operating and investing activities was $28.9 million for the first quarter of 2026; quarter-end cash and restricted cash position was $330.3 million Prothena updates projected full year 2026 net cash used in operating and investing actives to be $18 to $23 million (versus prior guidance $50 to $55 million) and expects to end the year with approximately $273 million (midpoint)…
High-Single Digit Revenue Growth for the Enterprise; Affirming FY-2026 Organic Revenue Outlook Quarterly Financial Highlights (All comparisons are year-over-year, unless otherwise noted) Net earnings per share (EPS) of $1.59, down 7.0% compared with $1.71; Adjusted EPS of $1.80, down 3.2% compared with $1.86 Revenues of $1,033.6 million, up 9.7% on a reported basis and up 2.6% on an organic basis…
Janus Henderson Group plc (NYSE: JHG) (“Janus Henderson” or the “Company”) will announce its first quarter 2026 results after market close on Friday, May 8, 2026. While the previously announced take-private transaction with Trian Fund Management, L.P. and its affiliated funds, and General Catalyst Group Management, LLC and its affiliated funds remains pending, the Company [...]
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will report its fourth quarter and full year 2025 financial results on Thursday, February 19, 2026, after the close of the U.S. financial markets. The announcement will be followed by [...]
Luxfer Holdings PLC (NYSE: LXFR) (“Luxfer” or the “Company”), a global industrial company innovating niche applications in materials engineering, today announced the details for its fourth quarter and full-year 2025 earnings conference call. Date and time: Wednesday, February 25, 2026, at 8:30 a.m. Eastern Time Luxfer participants: Andy Butcher Chief Executive Officer Steve Webster [...]
Delivered solid top and bottom-line performance & advanced strategic priorities in 2025 Launched sale process for the Food Ingredients segment Continuing to drive financial performance in 2026
Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Wednesday, Feb. 25, 2026 to discuss the company’s fourth quarter and year-end 2025 financial results. Management will also discuss financial expectations for 2026 and provide an update on the company. The webcast player and accompanying [...]
Page 1